OncoCyte Corp (OCX) - Product Pipeline Analysis, 2024 Update

Summary

OncoCyte Corp (OncoCyte) is a molecular diagnostic company that develops solutions for the detection and treatment of cancer. The company's products include graftassure test kit and determaio. It offers determacni testing services, clinical trials, clinical lab services, kidney transplant monitoring test, among others. It markets its products under GraftAssure, VitaGraft and DetermaIO. The company's tests are used in clinical trials conducted by pharmaceutical companies. The company operates primarily in the United States, serving healthcare providers, patients, and pharmaceutical companies across the country. OncoCyte is headquartered in Irvine, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company OncoCyte Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


OncoCyte Corp Company Overview
OncoCyte Corp Company Snapshot
OncoCyte Corp Pipeline Products and Ongoing Clinical Trials Overview
OncoCyte Corp – Pipeline Analysis Overview
OncoCyte Corp - Key Facts
OncoCyte Corp - Major Products and Services
OncoCyte Corp Pipeline Products by Development Stage
OncoCyte Corp Ongoing Clinical Trials by Trial Status
OncoCyte Corp Pipeline Products Overview
ALK Resistance Monitoring Assay
ALK Resistance Monitoring Assay Product Overview
Breast Confirmatory BI RADS 3-4 Assay
Breast Confirmatory BI RADS 3-4 Assay Product Overview
Companion Diagnostic Test - Alzheimer’s Disease
Companion Diagnostic Test - Alzheimer’s Disease Product Overview
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis Product Overview
Companion Diagnostic Test - Breast Cancer
Companion Diagnostic Test - Breast Cancer Product Overview
Companion Diagnostic Test - Chronic Fatigue Syndrome
Companion Diagnostic Test - Chronic Fatigue Syndrome Product Overview
Companion Diagnostic Test - Colorectal Cancer
Companion Diagnostic Test - Colorectal Cancer Product Overview
Companion Diagnostic Test - Multiple Sclerosis
Companion Diagnostic Test - Multiple Sclerosis Product Overview
Companion Diagnostic Test - Parkinson’s Disease
Companion Diagnostic Test - Parkinson’s Disease Product Overview
Companion Diagnostic Test - Prostate Cancer
Companion Diagnostic Test - Prostate Cancer Product Overview
Companion Diagnostic Test - Rheumatoid Arthritis
Companion Diagnostic Test - Rheumatoid Arthritis Product Overview
Dense Breast Tissue Confirmatory Test - Breast Cancer
Dense Breast Tissue Confirmatory Test - Breast Cancer Product Overview
DetermaCNI
DetermaCNI Product Overview
DetermaDx
DetermaDx Product Overview
DetermaIO
DetermaIO Product Overview
DetermaIO Clinical Trial
DetermaMX
DetermaMX Product Overview
DetermaTx
DetermaTx Product Overview
Diagnostic Assay - Amyloidosis
Diagnostic Assay - Amyloidosis Product Overview
Diagnostic Assay - Autism Spectrum Disorder
Diagnostic Assay - Autism Spectrum Disorder Product Overview
Diagnostic Assay - HPV
Diagnostic Assay - HPV Product Overview
Diagnostic Assay - Type I Diabetes
Diagnostic Assay - Type I Diabetes Product Overview
Diagnostic Test - Brain Cancer
Diagnostic Test - Brain Cancer Product Overview
Diagnostic Test - Gulf War Illnesses
Diagnostic Test - Gulf War Illnesses Product Overview
Diagnostic Test - Huntington's Disease
Diagnostic Test - Huntington's Disease Product Overview
Diagnostic Test - Lung Cancer
Diagnostic Test - Lung Cancer Product Overview
Diagnostic Test - Ovarian Cancer
Diagnostic Test - Ovarian Cancer Product Overview
Diagnostic Test - Systemic Lupus Erythematous
Diagnostic Test - Systemic Lupus Erythematous Product Overview
Insight ALK ECD Assay
Insight ALK ECD Assay Product Overview
Insight DEPDC1 Screen Assay
Insight DEPDC1 Screen Assay Product Overview
Insight ROS1 Fusion Screen Assay
Insight ROS1 Fusion Screen Assay Product Overview
KIR/KIR-Ligand LDT Assay
KIR/KIR-Ligand LDT Assay Product Overview
Lung Screening Assay
Lung Screening Assay Product Overview
Next-Generation DetermaVu
Next-Generation DetermaVu Product Overview
NGS Lung Panel Test
NGS Lung Panel Test Product Overview
PanC-Dx - Bladder Cancer
PanC-Dx - Bladder Cancer Product Overview
PanC-Dx - Breast Cancer
PanC-Dx - Breast Cancer Product Overview
PanC-Dx - Colon Cancer
PanC-Dx - Colon Cancer Product Overview
PanC-Dx - Lung Cancer
PanC-Dx - Lung Cancer Product Overview
PanC-Dx - Prostate Cancer
PanC-Dx - Prostate Cancer Product Overview
Therapeutic Monitoring Test - Pancreatic Cancer
Therapeutic Monitoring Test - Pancreatic Cancer Product Overview
Tumor Type 4 Assay
Tumor Type 4 Assay Product Overview
VitaGraft Kidney
VitaGraft Kidney Product Overview
OncoCyte Corp - Key Competitors
OncoCyte Corp - Key Employees
OncoCyte Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
OncoCyte Corp, Recent Developments
Aug 12, 2024: Oncocyte’s VitaGraft Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Jun 03, 2024: Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
Dec 06, 2023: Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays
Aug 28, 2023: Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
Aug 03, 2023: Oncocyte to Announce Second Quarter 2023 Financial Results
Jul 25, 2023: VitaGraft Kidney Expands Utility in Recurrent Primary Disease Patients
Jun 27, 2023: Oncocyte Begins Manufacturing Transplant Blood Test
Jun 27, 2023: Oncocyte Begins Manufacturing Transplant Blood Test
May 31, 2023: Hummingbird Diagnostics to present poster on miLung small RNA-Based Blood Test at the ASCO 2023 Annual Meeting
Apr 18, 2023: Oncocyte presents new data at AACR
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
OncoCyte Corp Pipeline Products and Ongoing Clinical Trials Overview
OncoCyte Corp Pipeline Products by Equipment Type
OncoCyte Corp Pipeline Products by Indication
OncoCyte Corp Ongoing Clinical Trials by Trial Status
OncoCyte Corp, Key Facts
OncoCyte Corp, Major Products and Services
OncoCyte Corp Number of Pipeline Products by Development Stage
OncoCyte Corp Pipeline Products Summary by Development Stage
OncoCyte Corp Ongoing Clinical Trials by Trial Status
OncoCyte Corp Ongoing Clinical Trials Summary
ALK Resistance Monitoring Assay - Product Status
ALK Resistance Monitoring Assay - Product Description
Breast Confirmatory BI RADS 3-4 Assay - Product Status
Breast Confirmatory BI RADS 3-4 Assay - Product Description
Companion Diagnostic Test - Alzheimer’s Disease - Product Status
Companion Diagnostic Test - Alzheimer’s Disease - Product Description
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Status
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Description
Companion Diagnostic Test - Breast Cancer - Product Status
Companion Diagnostic Test - Breast Cancer - Product Description
Companion Diagnostic Test - Chronic Fatigue Syndrome - Product Status
Companion Diagnostic Test - Chronic Fatigue Syndrome - Product Description
Companion Diagnostic Test - Colorectal Cancer - Product Status
Companion Diagnostic Test - Colorectal Cancer - Product Description
Companion Diagnostic Test - Multiple Sclerosis - Product Status
Companion Diagnostic Test - Multiple Sclerosis - Product Description
Companion Diagnostic Test - Parkinson’s Disease - Product Status
Companion Diagnostic Test - Parkinson’s Disease - Product Description
Companion Diagnostic Test - Prostate Cancer - Product Status
Companion Diagnostic Test - Prostate Cancer - Product Description
Companion Diagnostic Test - Rheumatoid Arthritis - Product Status
Companion Diagnostic Test - Rheumatoid Arthritis - Product Description
Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Status
Dense Breast Tissue Confirmatory Test - Breast Cancer - Product Description
DetermaCNI - Product Status
DetermaCNI - Product Description
DetermaDx - Product Status
DetermaDx - Product Description
DetermaIO - Product Status
DetermaIO - Product Description
DetermaIO - A Randomized, Phase Iii Trial to Evaluate the Efficacy and Safety of Pembrolizumab (Mk-3475) as Adjuvant Therapy for Triple Receptor-negative Breast Cancer with ≫/= 1 Cm Residual Invasive Cancer or Positive Lymph Nodes (Ypn1mi, Ypn1-3) after Neoadjuvant Chemotherapy
DetermaMX - Product Status
DetermaMX - Product Description
DetermaTx - Product Status
DetermaTx - Product Description
Diagnostic Assay - Amyloidosis - Product Status
Diagnostic Assay - Amyloidosis - Product Description
Diagnostic Assay - Autism Spectrum Disorder - Product Status
Diagnostic Assay - Autism Spectrum Disorder - Product Description
Diagnostic Assay - HPV - Product Status
Diagnostic Assay - HPV - Product Description
Diagnostic Assay - Type I Diabetes - Product Status
Diagnostic Assay - Type I Diabetes - Product Description
Diagnostic Test - Brain Cancer - Product Status
Diagnostic Test - Brain Cancer - Product Description
Diagnostic Test - Gulf War Illnesses - Product Status
Diagnostic Test - Gulf War Illnesses - Product Description
Diagnostic Test - Huntington's Disease - Product Status
Diagnostic Test - Huntington's Disease - Product Description
Diagnostic Test - Lung Cancer - Product Status
Diagnostic Test - Lung Cancer - Product Description
Diagnostic Test - Ovarian Cancer - Product Status
Diagnostic Test - Ovarian Cancer - Product Description
Diagnostic Test - Systemic Lupus Erythematous - Product Status
Diagnostic Test - Systemic Lupus Erythematous - Product Description
Insight ALK ECD Assay - Product Status
Insight ALK ECD Assay - Product Description
Insight DEPDC1 Screen Assay - Product Status
Insight DEPDC1 Screen Assay - Product Description
Insight ROS1 Fusion Screen Assay - Product Status
Insight ROS1 Fusion Screen Assay - Product Description
KIR/KIR-Ligand LDT Assay - Product Status
KIR/KIR-Ligand LDT Assay - Product Description
Lung Screening Assay - Product Status
Lung Screening Assay - Product Description
Next-Generation DetermaVu - Product Status
Next-Generation DetermaVu - Product Description
NGS Lung Panel Test - Product Status
NGS Lung Panel Test - Product Description
PanC-Dx - Bladder Cancer - Product Status
PanC-Dx - Bladder Cancer - Product Description
PanC-Dx - Breast Cancer - Product Status
PanC-Dx - Breast Cancer - Product Description
PanC-Dx - Colon Cancer - Product Status
PanC-Dx - Colon Cancer - Product Description
PanC-Dx - Lung Cancer - Product Status
PanC-Dx - Lung Cancer - Product Description
PanC-Dx - Prostate Cancer - Product Status
PanC-Dx - Prostate Cancer - Product Description
Therapeutic Monitoring Test - Pancreatic Cancer - Product Status
Therapeutic Monitoring Test - Pancreatic Cancer - Product Description
Tumor Type 4 Assay - Product Status
Tumor Type 4 Assay - Product Description
VitaGraft Kidney - Product Status
VitaGraft Kidney - Product Description
OncoCyte Corp, Key Employees
OncoCyte Corp, Other Locations
OncoCyte Corp, Subsidiaries
Glossary
List of Figures
OncoCyte Corp Pipeline Products by Equipment Type
OncoCyte Corp Pipeline Products by Development Stage
OncoCyte Corp Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings